Clinical Trial Update: A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A randomized Phase 1/2 clinical trial evaluating low-dose anti-thymocyte globulin followed by adalimumab or verapamil in individuals with new-onset Type 1 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• Anti-thymocyte globulin (ATG) (anti-thymocyte globulin)
• Verapamil (verapamil)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Type 1 Diabetes, New Onset | Phase 1, Phase 2 | Status: RECRUITING